A detailed history of North Rock Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, North Rock Partners, LLC holds 20,542 shares of ABT stock, worth $2.14 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
20,542
Previous 18,303 12.23%
Holding current value
$2.14 Million
Previous $2.01 Million 15.89%
% of portfolio
0.2%
Previous 0.19%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$109.52 - $120.96 $245,215 - $270,829
2,239 Added 12.23%
20,542 $2.33 Million
Q4 2023

Feb 08, 2024

BUY
$90.19 - $110.4 $236,207 - $289,137
2,619 Added 16.7%
18,303 $2.01 Million
Q3 2023

Oct 24, 2023

BUY
$95.53 - $114.62 $50,821 - $60,977
532 Added 3.51%
15,684 $1.52 Million
Q2 2023

Aug 02, 2023

BUY
$100.78 - $112.29 $141,797 - $157,992
1,407 Added 10.24%
15,152 $1.65 Million
Q1 2023

May 03, 2023

SELL
$96.86 - $114.01 $256,775 - $302,240
-2,651 Reduced 16.17%
13,745 $1.39 Million
Q4 2022

Feb 01, 2023

SELL
$95.06 - $111.52 $1.19 Million - $1.39 Million
-12,489 Reduced 43.24%
16,396 $1.8 Million
Q3 2022

Nov 02, 2022

BUY
$96.76 - $112.03 $58,152 - $67,330
601 Added 2.12%
28,885 $2.8 Million
Q2 2022

Aug 04, 2022

SELL
$102.07 - $123.37 $52,872 - $63,905
-518 Reduced 1.8%
28,284 $3.07 Million
Q1 2022

May 05, 2022

SELL
$114.02 - $139.04 $17,673 - $21,551
-155 Reduced 0.54%
28,802 $3.41 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $269,993 - $330,592
2,337 Added 8.78%
28,957 $4.08 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $191,905 - $212,303
1,645 Added 6.59%
26,620 $3.22 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $304,886 - $358,895
2,882 Added 13.04%
24,975 $2.9 Million
Q1 2021

May 11, 2021

BUY
$108.84 - $128.23 $4,462 - $5,257
41 Added 0.19%
22,093 $2.65 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $131,670 - $143,482
-1,254 Reduced 5.38%
22,052 $2.41 Million
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $2.14 Million - $2.59 Million
23,306 New
23,306 $2.54 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $4.19 Million - $5.36 Million
-54,722 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $2.71 Million - $3.96 Million
43,152 Added 372.96%
54,722 $4.32 Million
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $2.04 Million - $2.27 Million
-25,970 Reduced 69.18%
11,570 $1.01 Million
Q4 2019

Feb 12, 2020

BUY
$78.51 - $87.4 $1.93 Million - $2.15 Million
24,609 Added 190.31%
37,540 $1.01 Million
Q3 2019

Nov 12, 2019

BUY
$81.84 - $88.74 $1.06 Million - $1.15 Million
12,931 New
12,931 $1.08 Million
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $2.31 Million - $2.8 Million
-34,930 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $2.29 Million - $2.59 Million
34,930 New
34,930 $2.53 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track North Rock Partners, LLC Portfolio

Follow North Rock Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Rock Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on North Rock Partners, LLC with notifications on news.